table of content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2023-2028)
1.4.2 East Asia Market States and Outlook (2023-2028)
1.4.3 Europe Market States and Outlook (2023-2028)
1.4.4 South Asia Market States and Outlook (2023-2028)
1.4.5 Southeast Asia Market States and Outlook (2023-2028)
1.4.6 Middle East Market States and Outlook (2023-2028)
1.4.7 Africa Market States and Outlook (2023-2028)
1.4.8 Oceania Market States and Outlook (2023-2028)
1.4.9 South America Market States and Outlook (2023-2028)
1.5 Global Diabetes Management Devices Market Size Analysis from 2023 to 2028
1.5.1 Global Diabetes Management Devices Market Size Analysis from 2023 to 2028 by Consumption Volume
1.5.2 Global Diabetes Management Devices Market Size Analysis from 2023 to 2028 by Value
1.5.3 Global Diabetes Management Devices Price Trends Analysis from 2023 to 2028
1.6 COVID-19 Outbreak: Diabetes Management Devices Industry Impact
Chapter 2 Global Diabetes Management Devices Competition by Types, Applications, and Top Regions and Countries
2.1 Global Diabetes Management Devices (Volume and Value) by Type
2.1.1 Global Diabetes Management Devices Consumption and Market Share by Type (2017-2022)
2.1.2 Global Diabetes Management Devices Revenue and Market Share by Type (2017-2022)
2.2 Global Diabetes Management Devices (Volume and Value) by Application
2.2.1 Global Diabetes Management Devices Consumption and Market Share by Application (2017-2022)
2.2.2 Global Diabetes Management Devices Revenue and Market Share by Application (2017-2022)
2.3 Global Diabetes Management Devices (Volume and Value) by Regions
2.3.1 Global Diabetes Management Devices Consumption and Market Share by Regions (2017-2022)
2.3.2 Global Diabetes Management Devices Revenue and Market Share by Regions (2017-2022)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2017-2022 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2017-2022 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2017-2022 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Diabetes Management Devices Sales, Consumption, Export, Import by Regions (2017-2022)
4.1 Global Diabetes Management Devices Consumption by Regions (2017-2022)
4.2 North America Diabetes Management Devices Sales, Consumption, Export, Import (2017-2022)
4.3 East Asia Diabetes Management Devices Sales, Consumption, Export, Import (2017-2022)
4.4 Europe Diabetes Management Devices Sales, Consumption, Export, Import (2017-2022)
4.5 South Asia Diabetes Management Devices Sales, Consumption, Export, Import (2017-2022)
4.6 Southeast Asia Diabetes Management Devices Sales, Consumption, Export, Import (2017-2022)
4.7 Middle East Diabetes Management Devices Sales, Consumption, Export, Import (2017-2022)
4.8 Africa Diabetes Management Devices Sales, Consumption, Export, Import (2017-2022)
4.9 Oceania Diabetes Management Devices Sales, Consumption, Export, Import (2017-2022)
4.10 South America Diabetes Management Devices Sales, Consumption, Export, Import (2017-2022)
Chapter 5 North America Diabetes Management Devices Market Analysis
5.1 North America Diabetes Management Devices Consumption and Value Analysis
5.1.1 North America Diabetes Management Devices Market Under COVID-19
5.2 North America Diabetes Management Devices Consumption Volume by Types
5.3 North America Diabetes Management Devices Consumption Structure by Application
5.4 North America Diabetes Management Devices Consumption by Top Countries
5.4.1 United States Diabetes Management Devices Consumption Volume from 2017 to 2022
5.4.2 Canada Diabetes Management Devices Consumption Volume from 2017 to 2022
5.4.3 Mexico Diabetes Management Devices Consumption Volume from 2017 to 2022
Chapter 6 East Asia Diabetes Management Devices Market Analysis
6.1 East Asia Diabetes Management Devices Consumption and Value Analysis
6.1.1 East Asia Diabetes Management Devices Market Under COVID-19
6.2 East Asia Diabetes Management Devices Consumption Volume by Types
6.3 East Asia Diabetes Management Devices Consumption Structure by Application
6.4 East Asia Diabetes Management Devices Consumption by Top Countries
6.4.1 China Diabetes Management Devices Consumption Volume from 2017 to 2022
6.4.2 Japan Diabetes Management Devices Consumption Volume from 2017 to 2022
6.4.3 South Korea Diabetes Management Devices Consumption Volume from 2017 to 2022
Chapter 7 Europe Diabetes Management Devices Market Analysis
7.1 Europe Diabetes Management Devices Consumption and Value Analysis
7.1.1 Europe Diabetes Management Devices Market Under COVID-19
7.2 Europe Diabetes Management Devices Consumption Volume by Types
7.3 Europe Diabetes Management Devices Consumption Structure by Application
7.4 Europe Diabetes Management Devices Consumption by Top Countries
7.4.1 Germany Diabetes Management Devices Consumption Volume from 2017 to 2022
7.4.2 UK Diabetes Management Devices Consumption Volume from 2017 to 2022
7.4.3 France Diabetes Management Devices Consumption Volume from 2017 to 2022
7.4.4 Italy Diabetes Management Devices Consumption Volume from 2017 to 2022
7.4.5 Russia Diabetes Management Devices Consumption Volume from 2017 to 2022
7.4.6 Spain Diabetes Management Devices Consumption Volume from 2017 to 2022
7.4.7 Netherlands Diabetes Management Devices Consumption Volume from 2017 to 2022
7.4.8 Switzerland Diabetes Management Devices Consumption Volume from 2017 to 2022
7.4.9 Poland Diabetes Management Devices Consumption Volume from 2017 to 2022
Chapter 8 South Asia Diabetes Management Devices Market Analysis
8.1 South Asia Diabetes Management Devices Consumption and Value Analysis
8.1.1 South Asia Diabetes Management Devices Market Under COVID-19
8.2 South Asia Diabetes Management Devices Consumption Volume by Types
8.3 South Asia Diabetes Management Devices Consumption Structure by Application
8.4 South Asia Diabetes Management Devices Consumption by Top Countries
8.4.1 India Diabetes Management Devices Consumption Volume from 2017 to 2022
8.4.2 Pakistan Diabetes Management Devices Consumption Volume from 2017 to 2022
8.4.3 Bangladesh Diabetes Management Devices Consumption Volume from 2017 to 2022
Chapter 9 Southeast Asia Diabetes Management Devices Market Analysis
9.1 Southeast Asia Diabetes Management Devices Consumption and Value Analysis
9.1.1 Southeast Asia Diabetes Management Devices Market Under COVID-19
9.2 Southeast Asia Diabetes Management Devices Consumption Volume by Types
9.3 Southeast Asia Diabetes Management Devices Consumption Structure by Application
9.4 Southeast Asia Diabetes Management Devices Consumption by Top Countries
9.4.1 Indonesia Diabetes Management Devices Consumption Volume from 2017 to 2022
9.4.2 Thailand Diabetes Management Devices Consumption Volume from 2017 to 2022
9.4.3 Singapore Diabetes Management Devices Consumption Volume from 2017 to 2022
9.4.4 Malaysia Diabetes Management Devices Consumption Volume from 2017 to 2022
9.4.5 Philippines Diabetes Management Devices Consumption Volume from 2017 to 2022
9.4.6 Vietnam Diabetes Management Devices Consumption Volume from 2017 to 2022
9.4.7 Myanmar Diabetes Management Devices Consumption Volume from 2017 to 2022
Chapter 10 Middle East Diabetes Management Devices Market Analysis
10.1 Middle East Diabetes Management Devices Consumption and Value Analysis
10.1.1 Middle East Diabetes Management Devices Market Under COVID-19
10.2 Middle East Diabetes Management Devices Consumption Volume by Types
10.3 Middle East Diabetes Management Devices Consumption Structure by Application
10.4 Middle East Diabetes Management Devices Consumption by Top Countries
10.4.1 Turkey Diabetes Management Devices Consumption Volume from 2017 to 2022
10.4.2 Saudi Arabia Diabetes Management Devices Consumption Volume from 2017 to 2022
10.4.3 Iran Diabetes Management Devices Consumption Volume from 2017 to 2022
10.4.4 United Arab Emirates Diabetes Management Devices Consumption Volume from 2017 to 2022
10.4.5 Israel Diabetes Management Devices Consumption Volume from 2017 to 2022
10.4.6 Iraq Diabetes Management Devices Consumption Volume from 2017 to 2022
10.4.7 Qatar Diabetes Management Devices Consumption Volume from 2017 to 2022
10.4.8 Kuwait Diabetes Management Devices Consumption Volume from 2017 to 2022
10.4.9 Oman Diabetes Management Devices Consumption Volume from 2017 to 2022
Chapter 11 Africa Diabetes Management Devices Market Analysis
11.1 Africa Diabetes Management Devices Consumption and Value Analysis
11.1.1 Africa Diabetes Management Devices Market Under COVID-19
11.2 Africa Diabetes Management Devices Consumption Volume by Types
11.3 Africa Diabetes Management Devices Consumption Structure by Application
11.4 Africa Diabetes Management Devices Consumption by Top Countries
11.4.1 Nigeria Diabetes Management Devices Consumption Volume from 2017 to 2022
11.4.2 South Africa Diabetes Management Devices Consumption Volume from 2017 to 2022
11.4.3 Egypt Diabetes Management Devices Consumption Volume from 2017 to 2022
11.4.4 Algeria Diabetes Management Devices Consumption Volume from 2017 to 2022
11.4.5 Morocco Diabetes Management Devices Consumption Volume from 2017 to 2022
Chapter 12 Oceania Diabetes Management Devices Market Analysis
12.1 Oceania Diabetes Management Devices Consumption and Value Analysis
12.2 Oceania Diabetes Management Devices Consumption Volume by Types
12.3 Oceania Diabetes Management Devices Consumption Structure by Application
12.4 Oceania Diabetes Management Devices Consumption by Top Countries
12.4.1 Australia Diabetes Management Devices Consumption Volume from 2017 to 2022
12.4.2 New Zealand Diabetes Management Devices Consumption Volume from 2017 to 2022
Chapter 13 South America Diabetes Management Devices Market Analysis
13.1 South America Diabetes Management Devices Consumption and Value Analysis
13.1.1 South America Diabetes Management Devices Market Under COVID-19
13.2 South America Diabetes Management Devices Consumption Volume by Types
13.3 South America Diabetes Management Devices Consumption Structure by Application
13.4 South America Diabetes Management Devices Consumption Volume by Major Countries
13.4.1 Brazil Diabetes Management Devices Consumption Volume from 2017 to 2022
13.4.2 Argentina Diabetes Management Devices Consumption Volume from 2017 to 2022
13.4.3 Columbia Diabetes Management Devices Consumption Volume from 2017 to 2022
13.4.4 Chile Diabetes Management Devices Consumption Volume from 2017 to 2022
13.4.5 Venezuela Diabetes Management Devices Consumption Volume from 2017 to 2022
13.4.6 Peru Diabetes Management Devices Consumption Volume from 2017 to 2022
13.4.7 Puerto Rico Diabetes Management Devices Consumption Volume from 2017 to 2022
13.4.8 Ecuador Diabetes Management Devices Consumption Volume from 2017 to 2022
Chapter 14 Company Profiles and Key Figures in Diabetes Management Devices Business
14.1 Abbott
14.1.1 Abbott Company Profile
14.1.2 Abbott Diabetes Management Devices Product Specification
14.1.3 Abbott Diabetes Management Devices Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.2 Dexcom
14.2.1 Dexcom Company Profile
14.2.2 Dexcom Diabetes Management Devices Product Specification
14.2.3 Dexcom Diabetes Management Devices Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.3 F. Hoffmann-La Roche
14.3.1 F. Hoffmann-La Roche Company Profile
14.3.2 F. Hoffmann-La Roche Diabetes Management Devices Product Specification
14.3.3 F. Hoffmann-La Roche Diabetes Management Devices Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.4 LifeScan
14.4.1 LifeScan Company Profile
14.4.2 LifeScan Diabetes Management Devices Product Specification
14.4.3 LifeScan Diabetes Management Devices Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.5 Medtronic
14.5.1 Medtronic Company Profile
14.5.2 Medtronic Diabetes Management Devices Product Specification
14.5.3 Medtronic Diabetes Management Devices Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.6 AgaMatrix
14.6.1 AgaMatrix Company Profile
14.6.2 AgaMatrix Diabetes Management Devices Product Specification
14.6.3 AgaMatrix Diabetes Management Devices Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.7 Animas
14.7.1 Animas Company Profile
14.7.2 Animas Diabetes Management Devices Product Specification
14.7.3 Animas Diabetes Management Devices Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.8 ARKRAY
14.8.1 ARKRAY Company Profile
14.8.2 ARKRAY Diabetes Management Devices Product Specification
14.8.3 ARKRAY Diabetes Management Devices Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.9 Ascensia Diabetes Care
14.9.1 Ascensia Diabetes Care Company Profile
14.9.2 Ascensia Diabetes Care Diabetes Management Devices Product Specification
14.9.3 Ascensia Diabetes Care Diabetes Management Devices Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.10 B. Braun Melsungen
14.10.1 B. Braun Melsungen Company Profile
14.10.2 B. Braun Melsungen Diabetes Management Devices Product Specification
14.10.3 B. Braun Melsungen Diabetes Management Devices Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.11 BD
14.11.1 BD Company Profile
14.11.2 BD Diabetes Management Devices Product Specification
14.11.3 BD Diabetes Management Devices Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.12 Beta Bionics
14.12.1 Beta Bionics Company Profile
14.12.2 Beta Bionics Diabetes Management Devices Product Specification
14.12.3 Beta Bionics Diabetes Management Devices Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.13 Bigfoot Biomedical
14.13.1 Bigfoot Biomedical Company Profile
14.13.2 Bigfoot Biomedical Diabetes Management Devices Product Specification
14.13.3 Bigfoot Biomedical Diabetes Management Devices Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.14 BIONIME USA
14.14.1 BIONIME USA Company Profile
14.14.2 BIONIME USA Diabetes Management Devices Product Specification
14.14.3 BIONIME USA Diabetes Management Devices Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.15 CellNovo
14.15.1 CellNovo Company Profile
14.15.2 CellNovo Diabetes Management Devices Product Specification
14.15.3 CellNovo Diabetes Management Devices Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.16 Eli Lilly
14.16.1 Eli Lilly Company Profile
14.16.2 Eli Lilly Diabetes Management Devices Product Specification
14.16.3 Eli Lilly Diabetes Management Devices Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.17 iHealth Labs
14.17.1 iHealth Labs Company Profile
14.17.2 iHealth Labs Diabetes Management Devices Product Specification
14.17.3 iHealth Labs Diabetes Management Devices Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.18 Insulet
14.18.1 Insulet Company Profile
14.18.2 Insulet Diabetes Management Devices Product Specification
14.18.3 Insulet Diabetes Management Devices Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.19 Nemaura Medical
14.19.1 Nemaura Medical Company Profile
14.19.2 Nemaura Medical Diabetes Management Devices Product Specification
14.19.3 Nemaura Medical Diabetes Management Devices Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.20 Nipro
14.20.1 Nipro Company Profile
14.20.2 Nipro Diabetes Management Devices Product Specification
14.20.3 Nipro Diabetes Management Devices Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.21 Nova Biomedical
14.21.1 Nova Biomedical Company Profile
14.21.2 Nova Biomedical Diabetes Management Devices Product Specification
14.21.3 Nova Biomedical Diabetes Management Devices Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.22 Novo Nordisk
14.22.1 Novo Nordisk Company Profile
14.22.2 Novo Nordisk Diabetes Management Devices Product Specification
14.22.3 Novo Nordisk Diabetes Management Devices Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.23 Panasonic Healthcare
14.23.1 Panasonic Healthcare Company Profile
14.23.2 Panasonic Healthcare Diabetes Management Devices Product Specification
14.23.3 Panasonic Healthcare Diabetes Management Devices Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.24 Prodigy Diabetes Care
14.24.1 Prodigy Diabetes Care Company Profile
14.24.2 Prodigy Diabetes Care Diabetes Management Devices Product Specification
14.24.3 Prodigy Diabetes Care Diabetes Management Devices Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.25 Sanofi
14.25.1 Sanofi Company Profile
14.25.2 Sanofi Diabetes Management Devices Product Specification
14.25.3 Sanofi Diabetes Management Devices Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.26 Senseonics
14.26.1 Senseonics Company Profile
14.26.2 Senseonics Diabetes Management Devices Product Specification
14.26.3 Senseonics Diabetes Management Devices Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.27 Tandem Diabetes Care
14.27.1 Tandem Diabetes Care Company Profile
14.27.2 Tandem Diabetes Care Diabetes Management Devices Product Specification
14.27.3 Tandem Diabetes Care Diabetes Management Devices Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.28 Trividia Health
14.28.1 Trividia Health Company Profile
14.28.2 Trividia Health Diabetes Management Devices Product Specification
14.28.3 Trividia Health Diabetes Management Devices Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.29 TypeZero Technologies
14.29.1 TypeZero Technologies Company Profile
14.29.2 TypeZero Technologies Diabetes Management Devices Product Specification
14.29.3 TypeZero Technologies Diabetes Management Devices Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.30 Valeritas
14.30.1 Valeritas Company Profile
14.30.2 Valeritas Diabetes Management Devices Product Specification
14.30.3 Valeritas Diabetes Management Devices Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.31 WellDoc
14.31.1 WellDoc Company Profile
14.31.2 WellDoc Diabetes Management Devices Product Specification
14.31.3 WellDoc Diabetes Management Devices Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Chapter 15 Global Diabetes Management Devices Market Forecast (2023-2028)
15.1 Global Diabetes Management Devices Consumption Volume, Revenue and Price Forecast (2023-2028)
15.1.1 Global Diabetes Management Devices Consumption Volume and Growth Rate Forecast (2023-2028)
15.1.2 Global Diabetes Management Devices Value and Growth Rate Forecast (2023-2028)
15.2 Global Diabetes Management Devices Consumption Volume, Value and Growth Rate Forecast by Region (2023-2028)
15.2.1 Global Diabetes Management Devices Consumption Volume and Growth Rate Forecast by Regions (2023-2028)
15.2.2 Global Diabetes Management Devices Value and Growth Rate Forecast by Regions (2023-2028)
15.2.3 North America Diabetes Management Devices Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.4 East Asia Diabetes Management Devices Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.5 Europe Diabetes Management Devices Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.6 South Asia Diabetes Management Devices Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.7 Southeast Asia Diabetes Management Devices Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.8 Middle East Diabetes Management Devices Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.9 Africa Diabetes Management Devices Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.10 Oceania Diabetes Management Devices Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.11 South America Diabetes Management Devices Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.3 Global Diabetes Management Devices Consumption Volume, Revenue and Price Forecast by Type (2023-2028)
15.3.1 Global Diabetes Management Devices Consumption Forecast by Type (2023-2028)
15.3.2 Global Diabetes Management Devices Revenue Forecast by Type (2023-2028)
15.3.3 Global Diabetes Management Devices Price Forecast by Type (2023-2028)
15.4 Global Diabetes Management Devices Consumption Volume Forecast by Application (2023-2028)
15.5 Diabetes Management Devices Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
